{
  "paper_id": "4dbf1ec16cd9a4f37f32d3a010ffbc83cccecf58",
  "metadata": {
    "title": "Visions \u0026 Reflections The SARS-CoV S glycoprotein",
    "coda_data_split": "train",
    "coda_paper_id": 5060,
    "coda_has_expert_labels": false,
    "subset": "custom_license"
  },
  "abstract": [
    {
      "original_text": "The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for CMLS Cellular and Molecular Life Sciences entry inhibitors. Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors.",
      "sentences": [
        [
          {
            "segment_text": "The severe acute respiratory syndrome-coronavirus ( SARS-CoV ) spike ( S ) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "It is also a major immunogen and a target for CMLS Cellular and Molecular Life Sciences entry inhibitors .",
            "crowd_label": "background"
          }
        ],
        [
          {
            "segment_text": "Recent rapid advances in our knowledge of the structure and function of this protein have lead to the development of a number of candidate vaccine immunogens and SARS-CoV entry inhibitors .",
            "crowd_label": "finding"
          }
        ]
      ]
    }
  ],
  "abstract_stats": {
    "paragraph_num": "1",
    "sentence_num": "3",
    "segment_num": "3",
    "token_num": "77"
  }
}